PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.40 Mil Enterprise Value: 36.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q3 2023 PAVmed Inc Earnings Call Transcript

Nov 15, 2023 / 01:30PM GMT
Release Date Price: €2.46 (+0.51%)
Operator

Good day and welcome to the PAVmed third quarter 2023 business update conference call. (Operator Instructions) Please also note that today's event is being recorded.

I would now like to turn the conference over to Michael Parks, Vice President of Investor Relations. Please go ahead, Michael.

Michael Parks
PAVmed Inc. - VP of IR

Thank you, operator. Good morning, everyone, and thank you for participating in today's third quarter 2023 business update call. The press release announcing our business update for the Company and financial results for the three and nine months ended September 30, 2023 is available on path on the PAVmed website. Please take a moment to read the disclaimer about forward-looking statements. The business update press release and the conference call both include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made.

Factors that could cause actual results to differ are described in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot